Abstract--The interaction between N-methyl 8-hydroxy quinoline methyl sulfate, a drug that absorbs erymathogenic near-ultraviolet radiation, and smectite was studied by X-ray powder diffraction (XRD) and adsorption and desorption techniques. From the adsorption studies, (1) the amount of the drug adsorbed by Na-smectite increased with the pH of the solution to pH 6.5 and then decreased as the pH was further increased; (2) the maximum amount adsorbed at pH 6.5 was 102 meq/100 g of clay; and (3) the maximum amount of drug adsorbed, according to the adsorption isotherms at pH 4, was close to the cation-exchange capacity of the smectite (80 meq/100 g). The XRD studies showed that the drug molecules were adsorbed in the interlayer space of smectite and that cation exchange was the chief mechanism responsible for these interactions. The results of the adsorption-desorption cycles of the drug by smectite showed that this clay is a good support for this compound. In addition, an alternative method was developed to obtain the intercalation compound to avoid the standard method of exchange by impregnation. The method consisted of grinding a mixture of the drug with the clay. The characteristics of the complex thus formed were similar to those of the complex formed by exchange at pH 4 to 7.
INTRODUCTION
Many clay minerals readily adsorb organic molecules and form interlayer complexes (see, e.g., Mortland, 1970; Theng, 1974; Ainsworth et al., 1987) , and clays are thus widely used as carriers for drugs. The adsorption phenomena, however, may change the physicochemical properties of the adsorbed products, and the suitability of some drugs for biological use can therefore be modified (Grim, 1962; Grim and Giiven, 1978) . Thus, several studies have been carried out on the possible use of clays as a matrix in drug preparation (McGinity and Lach, 1976; Sfinchez-Martin et al., 1981; Sfinchez-Camazano et al., 1987) . N-methyl 8-hydroxy quinoline methyl sulfate is a derivative of o-oxy quinoline and strongly absorbs erythematogenic near-ultraviolet radiation. It is not toxic and is commonly used to prevent sunburn and the effects of harmful radiation in soldering, by ultraviolet lamps, etc. As smectite is commonly used in the preparation of pomades and protective creams, a study of the interaction between smectite and this drug is of pharmaceutical interest.
This paper deals with the adsorption-desorption processes and the interaction mechanism between Nasmectite and N-methyl 8-hydroxy quinoline methyl sulfate. The properties of the complex thus formed (rapid formation, high stability, and slow desorption, if the complex/solution ratio is not too low), the fact that this drug is currently used in collyria and other pharmaceutical products, and the change observed in the color of the drug if pure (yellow) and if located in the interlayer space of the clay (orange), justify a study of the potential properties of the intercalation complex as a radiation shield, mainly for hard radiation in the near-ultraviolet range. During the course of this study, an easy, inexpensive method of forming the complex was found.
EXPERIMENTAL
The <2-~tm fraction of synthetic ALBAGEL-4444 montmorillonite (Drug and Chemicals Inc., Philadelphia, ref. 65659) was used in this study. This smectite was previously characterized by Vicente-Hernandez et al. (1983) . Its cation-exchange capacity, as determined by the ammonium acetate method (Gonzalez-Zapatero, 1966) , is 80 meq/100 g. A Na-exchanged product was prepared by successive treatments of the clay with neutral solutions of NaC1, followed by washing with distilled water and ethanol.
The N-methyl 8-hydroxy quinoline methyl sulfate was produced by the method developed by Faller et al. (1964) . Its pK, is 6.7 (Vicente et al., 1985) , and its formula is depicted below:
CH3
For the adsorption studies, 100 mg of Na-smectite and 50 ml of the solution (4 x 10 -3 M) were used at 40~ A water bath was used to maintain constant temperature, and the suspension was continuously shaken. All measurements were made in duplicate. The pure drug is yellow and changes to orange on dissolving in a basic medium; the intercalation complexes are orange.
The effect of pH on the adsorption of the drug on the smectite was studied by suspending 100 mg of smectite in aqueous solutions of N-methyl 8-hydroxy quinoline methyl sulfate (0.2 meq/50 ml) in the pH range 2-10. Preliminary experiments by the authors showed that shaking for 30 min was enough to attain the adsorption equilibrium; hence, in all experiments, the suspensions were shaken for 30 rain. The suspension was then centrifuged, and the equilibrium concentration in the transparent liquid was determined by ultraviolet spectroscopy (maximum absorption at 258 rim).
Adsorption was measured as a function of the concentration of drug in the solution, following a method similar to that described above to study the effect of pH. Nine different concentrations of N-methyl 8-hydroxy quinoline methyl sulfate in the range 0.018-0.40 meq/50 ml were used at pH 4. For the desorption studies, 100 or 600 mg of the smectite-drug complex (~92 meq/100 g of complex, equivalent to 102 meq of drug adsorbed on 100 g of clay), were suspended with aqueous solutions containing 2.925 g NaCl/liter and 0.745 g KC1/liter at pH 5.5, concentrations fairly similar to those of human perspiration. The suspension was placed in a water bath at 40~ and shaken continuously; after 15 min the suspension was centrifuged and 50% of the transparent liquid was withdrawn for analysis and renewed with fresh solution. This desorption process was repeated 6 more times, with shaking intervals of 15 min, and then once for 45 min.
Another set of interlayer complexes was obtained by grinding the smectite and the drug in a planetary mill (speed 400 rpm) equipped with an agate jar (capacity 300 cm 3) containing 20, 20-mm diameter balls of the same material.
Oriented aggregates (Brindley and Brown, 1980 ) of the Na-smectite and the smectite-drug complexes were examined by X-ray powder diffraction (XRD) using a Philips PW-1730 apparatus and Ni-filtered CuKa radiation (X = 1.5405/~), with a goniometer speed of 1~ min and automatic slits. The complexes were all washed with distilled water, the pH of which having been adjusted to that of the solution used to prepare the complex. For the samples obtained by grinding, randomly oriented powder was used instead of oriented aggregates to avoid desorption of the drug from the interlayer space during preparation of such aggregates.
The visible-ultraviolet/diffuse reflectance (v.-u.v./ d.r.) spectra of the samples in the range 880 to 230 nm were obtained in a Shimadzu UV-240 spectrophotom- eter provided with a diffuse reflectance accessory and a Shimadzu PR-1 graphic printer, using MgO as reference, and a slit of 5 nm. The sample was used in the form of self-supported discs (3 mm width, 25 mm diameter) obtained by compressing the powder in the sample-holder provided by the manufacturer. The application of this technique to inorganic chemistry (Simmons, 1974) , materials science (Jones and Klier, 1972) , analytical chemistry (Frei et al., 1975) and the surfaces of dispersed solids (Frei, 1976; Kellerman, 1979) has been discussed previously.
RESULTS AND DISCUSSION
The data on the effect of pH on the adsorption of the drug by the smectite are summarized in Table 1 . The amount of adsorbed drug increased with pH, reaching a maximum at pH 6.5. It then decreased as the pH was increased further. The amount adsorbed at pH 6.5 (close to the pI~ value for this compound, 6.7) was 102 meq/100 g. In the pH range 4-7 the amount of drug adsorbed was ~20% larger than the exchange capacity of the smectite (80 meq/100 g). The processes which might have been involved in the adsorption of N-methyl 8-hydroxy quinoline methyl sulfate onto the smectite at pH -> 3 can be represented as follows:
where A is N-methyl 8-hydroxy quinoline methyl sulfate, AH § is N-methyl 8-hydroxy quinolinium cation, and S-is the methyl sulfate anion. In solution, the drug dissociates as indicated by Eq. (1). The chief reaction is probably that depicted by Eq. (2), in which Na § cations are exchanged by AH § cations from the solution. At very low pH, some type of competition between H § and AH § (Eq. (3)) cations must exist for exchange with the interlayer Na+ cations, thereby decreasing the total uptake of the organic cation at low pH. At pH > pI~, the adsorption of the ionic species decreased as pH increased. If pH ~ pKa the amount adsorbed exceeded the exchange capacity of the clay. Thus, in addition to cation exchange, a partial uptake of neutral molecules must also have taken place.
The adsorption isotherm at pH 4 of N-methyl 8-hydroxy quinoline methyl sulfate on smectite is shown in Figure la . The maximum adsorption was 86 meq/ 100 mg (Table 2) , a value close to the exchange capacity of the clay. No additional adsorption was recorded, even if more drug was added. On plotting the data according to a Langmuir-type isotherm, a straight line is obtained (Figure 1 b) .
To check that adsorption of N-methyl 8-hydroxy quinoline methyl sulfate was really taking place in the interlayer space of the smectite, samples were prepared (1) 600 mg complex/50 ml solution; (2) 100 mg complex/ 50 ml solution; (3) drug concentration in parent complex.
using the Na-smectite and solutions of drug at different pHs and with different concentrations of the drug. The corresponding XRD patterns show that the N-methyl 8-hydroxy quinolinium cation did indeed penetrate into the interlayer space of smectite, progressively increasing the basal d(001) spacing of the complex (Table 2) . Assuming a basal spacing corresponding to dehydrated smectite of 9.6 ,~, the increase in d(001) was 4.87 at pH 2 and 7.38 /~ at pH 5 to 7. If the exchanged samples were washed several times with water at the same pH as the exchange solution, their XRD peaks corresponded to a shift of d(001). If the amount adsorbed was larger than the exchange capacity (i.e., samples exchanged at pH 4 to 7), d(001) shifted to 16.35 /k, thus confirming that adsorption in excess of the exchange capacity was due to weak van der Waals forces between the clay and the drug molecule. Alternatively, this decrease could be ascribed to reorientation of the adsorbed species in the interlayer space, but in such a case the exchange degree observed would not be larger than the maxium cation-exchange capacity, as determined by the ammonium acetate method. At high pHs, d(001) shifted to 14.71 ~. At very low pHs (2, 3), the observed shift was partly due to the large H + concentration and competition between the drug and protons to be adsorbed, thus leading to a partial desorption of the complex. For the sample obtained by grinding the smectite with the drug, the basal spacing measured was 16.98 /k, coinciding with that of the sample obtained by exchange at pH between 5 and 7, and several reflection (00 l) orders were recorded. As mentioned above, this sample was not washed to withdraw the drug in excess, ~ I0,2 A 300 500 700 (rim) and oriented aggregates were not used, in order to overcome the formation of the interlayer complex through the standard exchange method during washing or suspending. These results also indicate that the grinding procedure used did not modify the structure of the smectite. Figure 2 summarizes the results obtained for the desorption of the drug from the interlayer space of the clay. Such a study was carried out using solutions containing different solutes (NaC1 and KC1) at concentrations and pHs close to those of human perspiration, in order to work in conditions as close as possible to those real ones in pomades and creams. The method used involved successive extractions and renewals of 50% of the solutions. The data in Figure 2 correspond to the effect of concentration of the complex in the suspensions on the desorption rate. Starting with 100 mg of complex in 50 ml of solution, the desorption was nearly complete after 2 hr, whereas if the starting concentration of complex in solution was much larger, e.g., 600 mg (50 ml), the desorption was slower, and only 30% of the drug was desorbed after 2 hr.
As mentioned above, a change was observed in the color of the drug on forming the adsorption complex. This change may have been due to changes in the delocalization of the electronic density in the molecule of the drug. Whereas in the solid state and at pH <pKa the compound and its aqueous solution are yellow, at increased pH or if an intercalation compound was formed, the color changed to orange. The equilibria depicted below can be assumed: 
Simple dissociation of the ionic solid (i.e., that taking place in an acidic medium) apparently did not change the electronic distribution in the quinoline-like residue; hence, the color remained unchanged. If the solid was dissolved in a basic medium, however, the proton in the --OH group of the quinoline double-ring dissociated, and the electronic density on the oxygen atom was delocalized in the ring, as explained by conventional resonance structures. This delocalization led to a decrease in the electronic energy levels of the molecule, thus accounting for a shift towards lower wavelength of th e absorption in the visible range. Figure 3 shows the v.-u.v./d.r, spectra of the pure drug (spectrum c) and of the complexes obtained on grinding for 60 min (spectrum b) and by the standard exchange method (spectrum a). Both complexes contained the same drug/smectite ratio (~60 meq/100 g). The spectrum of unloaded smectite is also shown (spectrum d). As it can be seen in this figure, absorption in A i0.2 A 300 500 700 900 wo.vel encjt h (nm) Figure 5 . Visible-ultraviolet/diffuse reflectance spectra of drug/smectite complexes: (a) and Co) complex obtained by the standard exchange method; (c) and (d) complex obtained upon grinding; (e) untreated smectite. Blank was MgO for spectra (a), (c), and (e), and parent smectite for spectra (b) and (d).
(Absorbance in arbitrary units; 0.2 A = 0.2 absorbance units.) the visible and near-ultraviolet range was very much larger in both complexes (spectra a and b) than for the pure drug (spectrum c), despite the low concentration of drug in the complexes. 'Fhis increased absorbance was centered at about 500 nm. Moreover, incorporation of the drug very effectively increased the absorbance in the ultraviolet range (less than about 300 nm) compared with that of the drug or the smectite. The use of this drug-smectite system as a solar radiation shield is well founded, on the basis of the experimental data in Figure 3 . Figure 4 shows the spectra of complexes obtained following the exchange method with increasing amounts of drug. Even at the lowest level of drug incorporated in the interlayer space, a sharp increase in absorbance was noted at about 500-550 nm; whereas an absorption band at about 290 nm developed in the ultraviolet range.
To obtain a spectrum of the drug as it was located in the interlayer space, without a contribution from the support (smectite), spectra were recorded using unloaded smectite as reference instead of MgO ( Figure  5 ). The unloaded smectite was white and did not absorb light in the visible range; hence, the spectrum of a given complex (obtained by exchange or by grinding) are recorded vs. the parent smectite between about 250 and 330 nm must have been due to the presence of the drug in the interlayer space. The spectrum of the pure drug (Figure 3c ) displays an absorption band close to 290 nm; in the differential spectrum of the complexes, this band was wider and more intense, suggesting that formation of the interlayer complex increased the absorption power of the drug, probably due to a change in the delocalization of the electronic density of the molecule.
Spectra 3b and 5c correspond to complexes obtained by grinding, with nearly the same drug/smectite ratio. Although the spectra are quite similar in the ultraviolet range, important differences are observed on the long wavelength side of the main absorption band at about 400 nm. This finding was unexpected, inasmuch as the drug/smectite ratio was the same. The only explanation for these differences is that the preparation of the samples for spectroscopic examination was different. In general, samples were ground to a very fine powder and then compressed to obtain discs. The effect of increasing in grinding time (equivalent to compressing to obtain discs) was therefore checked. The variation in absorbance of the main absorption bands at 390 and 250 nm with grinding time of the sample is shown in Figure 6 . Whereas for the unground sample only the band at ~ 280 nm and a broad, weak, shoulder at 350-450 nm were recorded, as the grinding time was increased the main band at ~400 nm rapidly developed, as did the shoulder at longer wavelengths, until a spectrum almost coincident with that of the complex obtained by the conventional exchange method was produced (Figures 3a and 3b ). These findings suggest that an aqueous medium (at least, as employed during the conventional exchange method) was not strictly necessary to introduce the drug in the interlayer space of the smectite. Prolonged grinding (i.e., if grinding and mixing act together in the mill) produced the same effect. From the spectra shown in Figure 6 , grinding for ~ 30 min was apparently enough to obtain the complex.
Although the conventional exchange method is widely used, the results here obtained clearly show that, alternatively, grinding without solvent is sufficient to obtain such an intercalation complex. Nevertheless, taking into account the XRD data, this method clearly leads to a complex in which some oversaturation of the drug exists (i.e., adsorption > the exchange capacity of the smectite). The basal spacing obtained was the same as that of the complex obtained at pH 7, but it decreased on washing (see Table 1 ). As mentioned above, this oversaturation was probably due to additional adsorption by van der Waals forces.
The reason why this grinding method led to a complex similar to that obtained at pH 7, but not to that obtained at pH 4 (on the basis of the basal spacings measured for the corresponding complexes), is not clear, but is probably due to the facts that sodium was the exchange cation in the interlayer space of smectite and that because of the large amount of water adsorbed on the clay, a surface basic medium should have existed, thus making the grinding method in some extent sim- ilar to the exchange method in a neutral or basic medium.
SUMMARY AND CONCLUSIONS
From the XRD data, the treatment of smectite with an aqueous solution of N-methyl 8-hydroxy quinoline methyl sulfate resulted in adsorption of the N-methyl 8-hydroxy quinolinium cation in the interlayer space of the clay. This adsorption gave rise to the formation of a definite complex having a basal spacing of 16.35 /~. The chief adsorption mechanism was cation exchange, although additional adsorption (i.e., greater than the exchange capacity of the clay) seems to have been due to van der Waals forces.
In addition, the intercalation complex extended the absorption capacity of light by the drug in the visible range and well into the ultraviolet range, thereby making this complex a suitable solar shield. The complex has a high stability, thus slowing down the desorption of the drug and prolonging its efficiency. Bearing in mind that in typical uses of this drug, the conditions are close to those used in these tests, smectite appears to be a good carrier for N-methyl 8-hydroxy quinoline methyl sulfate for several pharmacological purposes. The discovery that grinding (and mixing) for a relatively short period of time is sufficient to obtain the intercalation complex suggests new ways to prepare such compounds by a cleaner, rapid, and cheaper method than conventional exchange methods.
